180 related articles for article (PubMed ID: 34433451)
21. Concurrent endometrial carcinoma in patients with a curettage diagnosis of endometrial hyperplasia.
Chen YL; Cheng WF; Lin MC; Huang CY; Hsieh CY; Chen CA
J Formos Med Assoc; 2009 Jun; 108(6):502-7. PubMed ID: 19515631
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and management of endometrial hyperplasia: A UK national audit of adherence to national guidance 2012-2020.
Henderson I; Black N; Khattak H; ; Gupta JK; Rimmer MP
PLoS Med; 2024 Feb; 21(2):e1004346. PubMed ID: 38421942
[TBL] [Abstract][Full Text] [Related]
23. Hysteroscopic inspection and total curettage are insufficient for discriminating endometrial cancer from atypical endometrial hyperplasia.
Kurosawa H; Ito K; Nikura H; Takano T; Nagase S; Utsunomiya H; Otsuki T; Toyoshima M; Nagai T; Tanaka S; Watanabe M; Yaegashi N
Tohoku J Exp Med; 2012 Dec; 228(4):365-70. PubMed ID: 23154663
[TBL] [Abstract][Full Text] [Related]
24. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia.
Lacey JV; Sherman ME; Rush BB; Ronnett BM; Ioffe OB; Duggan MA; Glass AG; Richesson DA; Chatterjee N; Langholz B
J Clin Oncol; 2010 Feb; 28(5):788-92. PubMed ID: 20065186
[TBL] [Abstract][Full Text] [Related]
25. Preoperative and postoperative agreement of histopathological findings in cases of endometrial hyperplasia.
Kleebkaow P; Maneetab S; Somboonporn W; Seejornj K; Thinkhamrop J; Kamwilaisak R
Asian Pac J Cancer Prev; 2008; 9(1):89-91. PubMed ID: 18439083
[TBL] [Abstract][Full Text] [Related]
26. Endometrial hyperplasia in pre-menopausal women: A systematic review of incidence, prevalence, and risk factors.
Petersdorf K; Groettrup-Wolfers E; Overton PM; Seitz C; Schulze-Rath R
Eur J Obstet Gynecol Reprod Biol; 2022 Apr; 271():158-171. PubMed ID: 35217456
[TBL] [Abstract][Full Text] [Related]
27. [Incidence of endometrial cancer in patients with biopsy specimens of endometrial hyperplasia].
Zeferino-Toquero M; Bañuelos-Flores J; Maytorena-Córdova G; Reyna-Amaya H; Acevedo-Vega MF
Ginecol Obstet Mex; 2013 Sep; 81(9):519-24. PubMed ID: 24187815
[TBL] [Abstract][Full Text] [Related]
28. Clinical usefulness of color Doppler ultrasound in patients with endometrial hyperplasia and carcinoma.
Emoto M; Tamura R; Shirota K; Hachisuga T; Kawarabayashi T
Cancer; 2002 Feb; 94(3):700-6. PubMed ID: 11857302
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of endometrial cancer symptoms among overweight and obese women presenting to a multidisciplinary weight management center.
Beavis AL; Najjar O; Cheskin LJ; Mangal R; Rositch AF; Langham G; Fader AN
Gynecol Oncol Rep; 2020 Nov; 34():100643. PubMed ID: 32995455
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis and management of endometrial hyperplasia.
Armstrong AJ; Hurd WW; Elguero S; Barker NM; Zanotti KM
J Minim Invasive Gynecol; 2012; 19(5):562-71. PubMed ID: 22863972
[TBL] [Abstract][Full Text] [Related]
31. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
[TBL] [Abstract][Full Text] [Related]
32. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias.
Yang YF; Liao YY; Peng NF; Li LQ; Xie SR; Wang RB
Pathol Res Pract; 2012 Dec; 208(12):708-12. PubMed ID: 23044462
[TBL] [Abstract][Full Text] [Related]
33. Frozen section pathology at time of hysterectomy accurately predicts endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia.
Morotti M; Menada MV; Moioli M; Sala P; Maffeo I; Abete L; Fulcheri E; Menoni S; Venturini P; Papadia A
Gynecol Oncol; 2012 Jun; 125(3):536-40. PubMed ID: 22361087
[TBL] [Abstract][Full Text] [Related]
34. Risk for advanced-stage endometrial cancer in surgical specimens from patients with complex endometrial hyperplasia with atypia.
Eddib A; Allaf B; Lee J; Yeh J
Gynecol Obstet Invest; 2012; 73(1):38-42. PubMed ID: 22056948
[TBL] [Abstract][Full Text] [Related]
35. Cancer Incidence in Patients with Atypical Endometrial Hyperplasia Managed by Primary Hysterectomy or Fertility-sparing Treatment.
Gonthier C; Piel B; Touboul C; Walker F; Cortez A; Luton D; Daraï E; Koskas M
Anticancer Res; 2015 Dec; 35(12):6799-804. PubMed ID: 26637899
[TBL] [Abstract][Full Text] [Related]
36. Endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia.
Merisio C; Berretta R; De Ioris A; Pultrone DC; Rolla M; Giordano G; Tateo S; Melpignano M
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):107-11. PubMed ID: 16154046
[TBL] [Abstract][Full Text] [Related]
37. Patients with atypical hyperplasia of the endometrium should be treated in oncological centers.
Antonsen SL; Ulrich L; Høgdall C
Gynecol Oncol; 2012 Apr; 125(1):124-8. PubMed ID: 22198048
[TBL] [Abstract][Full Text] [Related]
38. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women.
Wise MR; Gill P; Lensen S; Thompson JM; Farquhar CM
Am J Obstet Gynecol; 2016 Nov; 215(5):598.e1-598.e8. PubMed ID: 27287687
[TBL] [Abstract][Full Text] [Related]
39. LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study.
Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK
Hum Reprod; 2013 Nov; 28(11):2966-71. PubMed ID: 23975691
[TBL] [Abstract][Full Text] [Related]
40. Predictors of endometrial carcinoma in patients with atypical endometrial hyperplasia at a tertiary gynaecological cancer centre in Western Australia.
Rajadurai VA; Chivers P; Ayres C; Mohan GR; Stewart CJR; Leung YC; Wan KM; Cohen PA
Aust N Z J Obstet Gynaecol; 2021 Apr; 61(2):275-283. PubMed ID: 33403680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
